Showing results (171-180 of 266) with videos related to
Sort By:
Pageof 27
Cancers|February 25, 2022
Escalated Maximum Dose in the Planning Target Volume Improves Local Control in Stereotactic Body Radiation Therapy for T1-2 Lung CancerTakaya Inagaki, Hiroshi Doi, Naoko Ishida, et al.Scandinavian Journal of Gastroenterology|November 9, 2021
Classification and clinical features of adverse drug reactions in patients with ulcerative colitis treated with 5-aminosalicylate acid: a single-center, observational studyYuri Tsujii, Tsutomu Nishida, Naoto Osugi, et al.European Journal of Radiology|February 8, 2011
Usefulness of administration of SPIO prior to RF ablation for evaluation of the therapeutic effect: an experimental study using miniature pigsSuguru Kakite, Shinya Fujii, Satoru Nakamatsu, et al.Case Reports in Gastroenterology|October 1, 2021
Immunoglobulin G4-Hepatopathy with Acute Hepatitis-Like Onset and Marked Centrilobular Necrosis: Clinicopathologically Unique Pattern of Hepatic Injury Related to Immunoglobulin G4-Related DiseaseKaori Mukai, Tsutomu Nishida, Shiro Adachi, et al.Clinical Journal of Gastroenterology|October 30, 2021
Nivolumab dose escalation triggered immune checkpoint inhibitor-induced colitis after 147 weeks of prolonged stable use in a patient with lung cancer: a case reportKazumasa Soma, Tsutomu Nishida, Naoto Osugi, et al.The American Journal of Tropical Medicine and Hygiene|March 18, 2021
Case Report: Ischemic Enterocolitis Associated with Coronavirus Disease 2019: Two Case Reports and a Review of the LiteratureTakeshi Kinjo, Akira Hokama, Hideta Nakamura, et al.Journal of Applied Clinical Medical Physics|August 2, 2021
An updating approach for knowledge-based planning models to improve plan quality and variability in volumetric-modulated arc therapy for prostate cancerKenji Nakamura, Katsuya Okuhata, Mikoto Tamura, et al.Japanese Journal of Clinical Oncology|July 20, 2012
Long-term follow-up of a randomized Phase II study of cisplatin/5-FU concurrent chemoradiotherapy for esophageal cancer (KROSG0101/JROSG021)Yasumasa Nishimura, Masahiro Hiraoka, Ryuta Koike, et al.Plos One|December 21, 2018
Correction: Radiation exposure dose and influencing factors during endoscopic retrograde cholangiopancreatographyShiro Hayashi, Tsutomu Nishida, Tokuhiro Matsubara, et al.Current Oncology (Toronto, Ont.)|August 28, 2024
Radiation-Induced Lymphopenia and Its Impact on Survival in Patients with Brain MetastasisNaoko Ishida, Yukinori Matsuo, Junki Fukuda, et al.Pageof 27